Circulating microRNA expression profile in B-cell acute lymphoblastic leukemia

Cancer Biomarkers

Volumn 15, Issue 3, 2015, Pages 299-310

  Luna Aguirre, Claudia Maribel ^a   Martinez Fierro, Margarita De La Luz ^b   Mar Aguilar, Fermín ^c   Garza Veloz, Idalia ^b   Treviño Alvaradod, Víctor ^c   Rojas Martinez, Augusto ^a,d   Jaime Perez, Jose Carlos ^e   Malagon Santiago, Guadalupe Ismael ^c   Gutierrez Aguirre, Cesar Homero ^e   Gonzalez Llano, Oscar ^e   Salazar Riojas, Rosario ^e   Hidalgo Miranda, Alfredo ^f   Martinez Rodriguez, Herminia Guadalupe ^a   Gomez Almaguer, David ^e   Ortiz Lopez, Rocio ^a,d  

^a Medicina UANL   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE ZACATECAS   (Mexico)

^c SCHOOL OF ENGINEERING AND SCIENCES   (Mexico)

^d UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

^e HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

^f INSTITUTO NACIONAL DE MEDICINA GENÓMICA   (Mexico)

Author keywords

Biomarkers; hematological malignancies; qRT PCR; signaling pathway

Indexed keywords

MICRORNA; MICRORNA 10B; MICRORNA 138; MICRORNA 140; MICRORNA 144; MICRORNA 146A; MICRORNA 155; MICRORNA 181A; MICRORNA 181C; MICRORNA 190B; MICRORNA 192; MICRORNA 199A; MICRORNA 221; MICRORNA 222; MICRORNA 223; MICRORNA 25; MICRORNA 26A; MICRORNA 320; MICRORNA 34A; MICRORNA 363; MICRORNA 422A; MICRORNA 451; MICRORNA 511; MICRORNA 565; MICRORNA 610; MICRORNA 630; MICRORNA 660; MICRORNA 886; MICRORNA 95; MICRORNA 99A; UNCLASSIFIED DRUG; TUMOR MARKER;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; B CELL LEUKEMIA; BLOOD SAMPLING; CANCER GENETICS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; LEUKEMOGENESIS; MALE; MEXICAN; POLYMERASE CHAIN REACTION SYSTEM; PRE B LYMPHOCYTE; PREDICTIVE VALUE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SENSITIVITY AND SPECIFICITY; BLOOD; CELL DIFFERENTIATION; CELL PROLIFERATION; DISEASE COURSE; GENE EXPRESSION PROFILING; INFANT; MIDDLE AGED; PHYSIOLOGY; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIOMARKERS, TUMOR; CELL DIFFERENTIATION; CELL PROLIFERATION; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INFANT; MALE; MICRORNAS; MIDDLE AGED; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; REAL-TIME POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 84931085883     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-150465     Document Type: Article

References (86)

1. C.H. Pui, L.L. Robison and A.T. Look, Acute lymphoblastic leukaemia, Lancet 371 (2008), 1030-43.
2. C.H. Pui and S. Jeha, New therapeutic strategies for the treatment of acute lymphoblastic leukaemia, Nat Rev Drug Discov 6 (2007), 149-65.
3. K. Nguyen, M. Devidas, S.C. Cheng, M. La, E.A. Raetz, W.L. Carroll, N.J. Winick, S.P. Hunger, P.S. Gaynon and M.L. Loh, Factors influencing survival after relapse from acute lymphoblastic leukemia: A Children's Oncology Group study, Leukemia 22 (2008), 2142-50.
4. C.H. Pui, M.V. Relling and J.R. Downing, Acute lymphoblastic leukemia, N Engl J Med 350 (2004), 1535-48.
5. V. Ambros, MicroRNA pathways in flies and worms: Growth, death, fat, stress, and timing, Cell 113 (2003), 673-6.
6. S. Volinia, G.A. Calin, C.G. Liu, S. Ambs, A. Cimmino, F. Petrocca, R. Visone, M. Iorio, C. Roldo, M. Ferracin, R.L. Prueitt, N. Yanaihara, G. Lanza, A. Scarpa, A. Vecchione, M. Negrini, C.C. Harris and C.M. Croce, A microRNA expression signature of human solid tumors defines cancer gene targets, Proc Natl Acad Sci USA 103 (2006), 2257-61.
7. A. Dixon-McIver, P. East, C.A. Mein, J.B. Cazier, G. Molloy, T. Chaplin, T. Andrew Lister, B.D. Young and S. Debernardi, Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia, PLoS One 3 (2008), e2141.
8. R. Garzon, S. Volinia, C.G. Liu, C. Fernandez-Cymering, T. Palumbo, F. Pichiorri, M. Fabbri, K. Coombes, H. Alder, T. Nakamura, N. Flomenberg, G. Marcucci, G.A. Calin, S.M. Kornblau, H. Kantarjian, C.D. Bloomfield, M. Andreeff and C.M. Croce, MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia, Blood 111 (2008), 3183-9.
9. Z. Li, J. Lu, M. Sun, S. Mi, H. Zhang, R.T. Luo, P. Chen, Y. Wang, M. Yan, Z. Qian, M.B. Neilly, J. Jin, Y. Zhang, S.K. Bohlander, D.E. Zhang, R.A. Larson, M.M. Le Beau, M.J. Thirman, T.R. Golub, J.D. Rowley and J. Chen, Distinct microRNA expression profiles in acute myeloid leukemia with common translocations, Proc Natl Acad Sci U S A 105 (2008), 15535-40.
10. M. Jongen-Lavrencic, S.M. Sun, M.K. Dijkstra, P.J. Valk and B. Lowenberg, MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia, Blood 111 (2008), 5078-85.
11. D. Schotte, R.X. De Menezes, F. Akbari Moqadam, L.M. Khankahdani, E. Lange-Turenhout, C. Chen, R. Pieters and M.L. Den Boer, MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia, Haematologica 96 (2011), 703-11.
12. G. Juliusson, D.G. Oscier, M. Fitchett, F.M. Ross, G. Stockdill, M.J. Mackie, A.C. Parker, G.L. Castoldi, A. Guneo, S. Knuutila, E. Elonen and G. Gahrton, Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities, N Engl J Med 323 (1990), 720-4.
13. B. F.G, Classification of Acute Leukemias, in: Treatment of Acute Leukemias: New Directions for Clinical Research, C.-H. Pui, ed. eds., Humana Press Stanford, CA, 2003, pp. 17.
14. J. Lu, G. Getz, E.A. Miska, E. Alvarez-Saavedra, J. Lamb, D. Peck, A. Sweet-Cordero, B.L. Ebert, R.H. Mak, A.A. Ferrando, J.R. Downing, T. Jacks, H.R. Horvitz and T.R. Golub, MicroRNA expression profiles classify human cancers, Nature 435 (2005), 834-8.
15. P.S. Mitchell, R.K. Parkin, E.M. Kroh, B.R. Fritz, S.K. Wyman, E.L. Pogosova-Agadjanyan, A. Peterson, J. Noteboom, K.C. O'Briant, A. Allen, D.W. Lin, N. Urban, C.W. Drescher, B.S. Knudsen, D.L. Stirewalt, R. Gentleman, R.L. Vessella, P.S. Nelson, D.B. Martin and M. Tewari, Circulating microRNAs as stable blood-based markers for cancer detection, Proc Natl Acad Sci USA 105 (2008), 10513-8.
16. E. Moussay, K. Wang, J.H. Cho, K. van Moer, S. Pierson, J. Paggetti, P.V. Nazarov, V. Palissot, L.E. Hood, G. Berchem and D.J. Galas, MicroRNA as biomarkers and regulators in B-cell chronic lymphocytic leukemia, Proc Natl Acad Sci U S A 108 (2011), 6573-8.
17. S.S. Chim, T.K. Shing, E.C. Hung, T.Y. Leung, T.K. Lau, R.W. Chiu and Y.M. Lo, Detection and characterization of placental microRNAs in maternal plasma, Clin Chem 54 (2008), 482-90.
18. B.W. Han, D.D. Feng, Z.G. Li, X.Q. Luo, H. Zhang, X.J. Li, X.J. Zhang, L.L. Zheng, C.W. Zeng, K.Y. Lin, P. Zhang, L. Xu and Y.Q. Chen, A set of miRNAs that involve in the pathways of drug resistance and leukemic stem-cell differentiation is associated with the risk of relapse and glucocorticoid response in childhood ALL, Hum Mol Genet 20 (2011), 4903-15.
19. M. Estep, D. Armistead, N. Hossain, H. Elarainy, Z. Goodman, A. Baranova, V. Chandhoke and Z.M. Younossi, Differential expression of miRNAs in the visceral adipose tissue of patients with non-alcoholic fatty liver disease, Aliment Pharmacol Ther 32 (2010), 487-97.
20. C.Y. Lai, S.L. Yu, M.H. Hsieh, C.H. Chen, H.Y. Chen, C.C. Wen, Y.H. Huang, P.C. Hsiao, C.K. Hsiao, C.M. Liu, P.C. Yang, H.G. Hwu and W.J. Chen, MicroRNA expression aberration as potential peripheral blood biomarkers for schizophrenia, PLoS One 6 (2011), e21635.
21. P. Mandke, N. Wyatt, J. Fraser, B. Bates, S.J. Berberich and M.P. Markey, MicroRNA-34a modulates MDM4 expression via a target site in the open reading frame, PLoS One 7 (2012), e42034.
22. C.S. Chim, K.Y. Wong, C.Y. Leung, L.P. Chung, P.K. Hui, S.Y. Chan and L. Yu, Epigenetic inactivation of the hsamiR-203 in haematological malignancies, J Cell Mol Med 15 (2011), 2760-7.
23. W. Gao, H. Shen, L. Liu, J. Xu and Y. Shu, MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis, J Cancer Res Clin Oncol 137 (2011), 557-66.
24. T. Song, W. Xia, N. Shao, X. Zhang, C. Wang, Y. Wu, J. Dong, W. Cai and H. Li, Differential miRNA expression profiles in bladder urothelial carcinomas, Asian Pac J Cancer Prev 11 (2010), 905-11.
25. S. Saini, S. Yamamura, S. Majid, V. Shahryari, H. Hirata, Y. Tanaka and R. Dahiya, MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells, Cancer Res 71 (2011), 6208-19.
26. S. Saini, S. Majid, V. Shahryari, S. Arora, S. Yamamura, I. Chang, M.S. Zaman, G. Deng, Y. Tanaka and R. Dahiya, miRNA-708 control of CD44(+) prostate cancer-initiating cells, Cancer Res 72 (2012), 3618-30.
27. J.S. Jang, H.S. Jeon, Z. Sun, M.C. Aubry, H. Tang, C.H. Park, F. Rakhshan, D.A. Schultz, C.P. Kolbert, R. Lupu, J.Y. Park, C.C. Harris, P. Yang and J. Jen, Increased miR-708 expression in NSCLC and its association with poor survival in lung adenocarcinoma from never smokers, Clin Cancer Res 18 (2012), 3658-67.
28. O. Giricz, P.A. Reynolds, A. Ramnauth, C. Liu, T. Wang, L. Stead, G. Childs, T. Rohan, N. Shapiro, S. Fineberg, P.A. Kenny and O. Loudig, Hsa-miR-375 is differentially expressed during breast lobular neoplasia and promotes loss of mammary acinar polarity, J Pathol 226 (2012), 108-19.
29. J. Imig, N. Motsch, J.Y. Zhu, S. Barth, M. Okoniewski, T. Reineke, M. Tinguely, A. Faggioni, P. Trivedi, G. Meister, C. Renner and F.A. Grasser, microRNA profiling in Epstein-Barr virus-associated B-cell lymphoma, Nucleic Acids Res 39 (2011), 1880-93.
30. Z. Zhang, Y. Kang, H. Zhang, X. Duan, J. Liu, X. Li and W. Liao, Expression of microRNAs during chondrogenesis of human adipose-derived stem cells, Osteoarthritis Cartilage 20 (2012), 1638-46.
31. H.J. Peltier and G.J. Latham, Normalization of microRNA expression levels in quantitative RT-PCR assays: Identification of suitable reference RNA targets in normal and cancerous human solid tissues, RNA 14 (2008), 844-52.
32. L. Morenos, R. Saffery, F. Mechinaud, D. Ashley, N. Elwood, J.M. Craig and N.C. Wong, Evaluation of microRNA expression in patient bone marrow aspirate slides, PLoS One 7 (2012), e42951.
33. P.A. Davoren, R.E. McNeill, A.J. Lowery, M.J. Kerin and N. Miller, Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer, BMC Mol Biol 9 (2008), 76.
34. E.M. Kroh, R.K. Parkin, P.S. Mitchell and M. Tewari, Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR), Methods 50 (2010), 298-301.
35. X. Ju, D. Li, Q. Shi, H. Hou, N. Sun and B. Shen, Differential microRNA expression in childhood B-cell precursor acute lymphoblastic leukemia, Pediatr Hematol Oncol 26 (2009), 1-10.
36. Y. Wang, Z. Li, C. He, D. Wang, X. Yuan, J. Chen and J. Jin, MicroRNAs expression signatures are associated with lineage and survival in acute leukemias, Blood Cells Mol Dis 44 (2010), 191-7.
37. A. Kotani, D. Ha, J. Hsieh, P.K. Rao, D. Schotte, M.L. den Boer, S.A. Armstrong and H.F. Lodish, miR-128b is a potent glucocorticoid sensitizer in MLL-AF4 acute lymphocytic leukemia cells and exerts cooperative effects with miR-221, Blood 114 (2009), 4169-78.
38. Y.D. Zhu, L. Wang, C. Sun, L. Fan, D.X. Zhu, C. Fang, Y.H. Wang, Z.J. Zou, S.J. Zhang, J.Y. Li and W. Xu, Distinctive microRNA signature is associated with the diagnosis and prognosis of acute leukemia, Med Oncol 29 (2012), 2323-31.
39. M. Cheung and J.R. Testa, Diverse mechanisms of AKT pathway activation in human malignancy, Curr Cancer Drug Targets (2013).
40. J. Cicenas, The potential role of Akt phosphorylation in human cancers, Int J Biol Markers 23 (2008), 1-9.
41. S. Konoplev, C.C. Yin, S.M. Kornblau, H.M. Kantarjian, M. Konopleva, M. Andreeff, G. Lu, Z. Zuo, R. Luthra, L.J. Medeiros and C.E. Bueso-Ramos, Molecular characterization of de novo Philadelphia chromosome-positive acute myeloid leukemia, Leuk Lymphoma 54 (2013), 138-44.
42. G. Marfe, C. Di Stefano, A. Gambacurta, T. Ottone, V. Martini, E. Abruzzese, L. Mologni, P. Sinibaldi-Salimei, P. de Fabritis, C. Gambacorti-Passerini, S. Amadori and R.B. Birge, Sphingosine kinase 1 overexpression is regulated by signaling through PI3K, AKT2, and mTOR in imatinib-resistant chronic myeloid leukemia cells, Exp Hematol 39 (2011), 653-665 e6.
43. S. Matsuura, Y. Komeno, K.E. Stevenson, J.R. Biggs, K. Lam, T. Tang, M.C. Lo, X. Cong, M. Yan, D.S. Neuberg and D.E. Zhang, Expression of the runt homology domain of RUNX1 disrupts homeostasis of hematopoietic stem cells and induces progression to myelodysplastic syndrome, Blood 120 (2012), 4028-37.
44. C. Roche-Lestienne, L. Deluche, S. Corm, I. Tigaud, S. Joha, N. Philippe, S. Geffroy, J.L. Lai, F.E. Nicolini and C. Preudhomme, RUNX1 DNA-binding mutations and RUNX1-PRDM16 cryptic fusions in BCR-ABL+ leukemias are frequently associated with secondary trisomy 21 and may contribute to clonal evolution and imatinib resistance, Blood 111 (2008), 3735-41.
45. D.X. Zhu, W. Zhu, C. Fang, L. Fan, Z.J. Zou, Y.H. Wang, P. Liu, M. Hong, K.R. Miao, W. Xu and J.Y. Li, miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes, Carcinogenesis 33 (2012), 1294-301.
46. R. Visone, L.Z. Rassenti, A. Veronese, C. Taccioli, S. Costinean, B.D. Aguda, S. Volinia, M. Ferracin, J. Palatini, V. Balatti, H. Alder, M. Negrini, T.J. Kipps and C.M. Croce, Karyotype-specific microRNA signature in chronic lymphocytic leukemia, Blood 114 (2009), 3872-9.
47. A. Bryant, C.A. Palma, V. Jayaswal, Y.W. Yang, M. Luther-borrow and D.D. Ma, miR-10a is aberrantly overexpressed in Nucleophosmin1 mutated acute myeloid leukaemia and its suppression induces cell death, Mol Cancer 11 (2012), 8.
48. R. Garzon, M. Garofalo, M.P. Martelli, R. Briesewitz, L. Wang, C. Fernandez-Cymering, S. Volinia, C.G. Liu, S. Schnittger, T. Haferlach, A. Liso, D. Diverio, M. Mancini, G. Meloni, R. Foa, M.F. Martelli, C. Mecucci, C.M. Croce and B. Falini, Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin, Proc Natl Acad Sci USA 105 (2008), 3945-50.
49. J. Fei, Y. Li, X. Zhu and X. Luo, miR-181a posttranscriptionally downregulates oncogenic RalA and contributes to growth inhibition and apoptosis in chronic myelogenous leukemia (CML), PLoS One 7 (2012), e32834.
50. Z. Li, H. Huang, Y. Li, X. Jiang, P. Chen, S. Arnovitz, M.D. Radmacher, K. Maharry, A. Elkahloun, X. Yang, C. He, M. He, Z. Zhang, K. Dohner, M.B. Neilly, C. Price, Y.A. Lussier, Y. Zhang, R.A. Larson, M.M. Le Beau, M.A. Caligiuri, L. Bullinger, P.J. Valk, R. Delwel, B. Lowenberg, P.P. Liu, G. Marcucci, C.D. Bloomfield, J.D. Rowley and J. Chen, Upregulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML, Blood 119 (2012), 2314-24.
51. K. Machova Polakova, T. Lopotova, H. Klamova, P. Burda, M. Trneny, T. Stopka and J. Moravcova, Expression patterns of microRNAs associated with CML phases and their disease related targets, Mol Cancer 10 (2011), 41.
52. G. Cammarata, L. Augugliaro, D. Salemi, C. Agueli, M. La Rosa, L. Dagnino, G. Civiletto, F. Messana, A. Marfia, M.G. Bica, L. Cascio, P.M. Floridia, A.M. Mineo, M. Russo, F. Fabbiano and A. Santoro, Differential expression of specific microRNA and their targets in acute myeloid leukemia, Am J Hematol 85 (2010), 331-9.
53. M. Frenquelli, M. Muzio, C. Scielzo, C. Fazi, L. Scarfo, C. Rossi, G. Ferrari, P. Ghia and F. Caligaris-Cappio, MicroRNA and proliferation control in chronic lymphocytic leukemia: Functional relationship between miR-221/222 cluster and p27, Blood 115 (2010), 3949-59.
54. M. Brioschi, J. Fischer, R. Cairoli, S. Rossetti, L. Pezzetti, M. Nichelatti, M. Turrini, F. Corlazzoli, B. Scarpati, E. Morra, N. Sacchi and A. Beghini, Down-regulation of microRNAs 222/221 in acute myelogenous leukemia with deranged core-binding factor subunits, Neoplasia 12 (2010), 866-76.
55. A.J. Favreau and P. Sathyanarayana, miR-590-5p, miR-219-5p, miR-15b and miR-628-5p are commonly regulated by IL-3, GM-CSF and G-CSF in acute myeloid leukemia, Leuk Res 36 (2012), 334-41.
56. R. Garzon, F. Pichiorri, T. Palumbo, M. Visentini, R. Aqeilan, A. Cimmino, H. Wang, H. Sun, S. Volinia, H. Alder, G.A. Calin, C.G. Liu, M. Andreeff and C.M. Croce, MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia, Oncogene 26 (2007), 4148-57.
57. C. Xu, H. Fu, L. Gao, L. Wang, W. Wang, J. Li, Y. Li, L. Dou, X. Gao, X. Luo, Y. Jing, C.S. Chim, X. Zheng and L. Yu, BCR-ABL/GATA1/miR-138 mini circuitry contributes to the leukemogenesis of chronic myeloid leukemia, Oncogene (2012).
58. K. Zhou, S. Yi, Z. Yu, Z. Li, Y. Wang, D. Zou, J. Qi, Y. Zhao and L. Qiu, MicroRNA-223 expression is uniformly downregulated in B cell lymphoproliferative disorders and is associated with poor survival in patients with chronic lymphocytic leukemia, Leuk Lymphoma 53 (2012), 1155-61.
59. S. Agatheeswaran, S. Singh, S. Biswas, G. Biswas, N. Chandra Pattnayak and S. Chakraborty, BCR-ABL mediated repression of miR-223 results in the activation of MEF2C and PTBP2 in chronic myeloid leukemia, Leukemia (2012).
60. S. Ninomiya, A. Tyybakinoja, I. Borze, R. Raty, U.M. Saarinen-Pihkala, A. Usvasalo, E. Elonen and S. Knuutila, Integrated analysis of gene copy number, copy neutral LOH, and microRNA profiles in adult acute lymphoblastic leukemia, Cytogenet Genome Res 136 (2012), 246-55.
61. J.H. Mendler, K. Maharry, M.D. Radmacher, K. Mrozek, H. Becker, K.H. Metzeler, S. Schwind, S.P. Whitman, J. Khalife, J. Kohlschmidt, D. Nicolet, B.L. Powell, T.H. Carter, M. Wetzler, J.O. Moore, J.E. Kolitz, M.R. Baer, A.J. Carroll, R.A. Larson, M.A. Caligiuri, G. Marcucci and C.D. Bloomfield, RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures, J Clin Oncol 30, 3109-18.
62. Y. Wu, X.F. Li, J.H. Yang, X.Y. Liao and Y.Z. Chen, [microR-NAs expression profile in acute promyelocytic leukemia cell differentiation induced by all-trans retinoic acid and arsenic trioxide], Zhonghua Xue Ye Xue Za Zhi 33 (2012), 546-51.
63. P. Jian, Z.W. Li, T.Y. Fang, W. Jian, Z. Zhuan, L.X. Mei, W.S. Yan and N. Jian, Retinoic acid induces HL-60 cell differentiation via the upregulation of miR-663, J Hematol Oncol 4 (2011), 20.
64. B. Salvatori, I. Iosue, A. Mangiavacchi, G. Loddo, F. Padula, S. Chiaretti, N. Peragine, I. Bozzoni, F. Fazi and A. Fatica, The microRNA-26a target E2F7 sustains cell proliferation and inhibits monocytic differentiation of acute myeloid leukemia cells, Cell Death Dis 3 (2012), e413.
65. K.J. Mavrakis, J. Van Der Meulen, A.L. Wolfe, X. Liu, E. Mets, T. Taghon, A.A. Khan, M. Setty, P. Rondou, P. Vandenberghe, E. Delabesse, Y. Benoit, N.B. Socci, C.S. Leslie, P. Van Vlierberghe, F. Speleman and H.G. Wendel, A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL), Nat Genet 43 (2011), 673-8.
66. T. Lopotova, M. Zackova, H. Klamova and J. Moravcova, MicroRNA-451 in chronic myeloid leukemia: miR-451-BCR-ABL regulatory loop?, Leuk Res 35 (2011), 974-7.
67. S. Willimott and S.D. Wagner, Stromal cells and CD40 ligand (CD154) alter the miRNome and induce miRNA clusters including, miR-125b/miR-99a/let-7c and miR-17-92 in chronic lymphocytic leukaemia, Leukemia 26 (2012), 1113-6.
68. O.H. Rokah, G. Granot, A. Ovcharenko, S. Modai, M. Pasmanik-Chor, A. Toren, N. Shomron and O. Shpilberg, Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells, PLoS One 7 (2012), e35501.
69. I. Faraoni, S. Laterza, D. Ardiri, C. Ciardi, F. Fazi and F. Lo-Coco, MiR-424 and miR-155 deregulated expression in cytogenetically normal acute myeloid leukaemia: Correlation with NPM1 and FLT3 mutation status, J Hematol Oncol 5 (2012), 26.
70. S. Bhatia, D. Kaul and N. Varma, Potential tumor suppressive function of miR-196b in B-cell lineage acute lymphoblastic leukemia, MolCellBiochem340 (2010), 97-106.
71. A.E. Rodriguez, J.A. Hernandez, R. Benito, N.C. Gutierrez, J.L. Garcia, M. Hernandez-Sanchez, A. Risueno, M.E. Sarasquete, E. Ferminan, R. Fisac, A.G. de Coca, G. Martin-Nunez, N. de Las Heras, I. Recio, O. Gutierrez, J. De Las Rivas, M. Gonzalez and J.M. Hernandez-Rivas, Molecular characterization of chronic lymphocytic leukemia patients with a high number of losses in 13q14, PLoS One 7 (2012), e48485.
72. J.A. Pulikkan, V. Dengler, P.S. Peramangalam, A.A. Peer Zada, C. Muller-Tidow, S.K. Bohlander, D.G. Tenen and G. Behre, Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia, Blood 115 (2010), 1768-78.
73. H. Zhong, H.R. Wang, S. Yang, J.H. Zhong, T. Wang, C. Wang and F.Y. Chen, Targeting Smad4 links microRNA-146a to the TGF-beta pathway during retinoid acid induction in acute promyelocytic leukemia cell line, Int J Hematol 92 (2010), 129-35.
74. S. Flamant, W. Ritchie, J. Guilhot, J. Holst, M.L. Bonnet, J.C. Chomel, F. Guilhot, A.G. Turhan and J.E. Rasko, Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia, Haematologica 95 (2010), 1325-33.
75. V. Fulci, T. Colombo, S. Chiaretti, M. Messina, F. Citarella, S. Tavolaro, A. Guarini, R. Foa and G. Macino, Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles, Genes Chromosomes Cancer 48 (2009), 1069-82.
76. D.J. Stumpel, D. Schotte, E.A. Lange-Turenhout, P. Schneider, L. Seslija, R.X. de Menezes, V.E. Marquez, R. Pieters, M.L. den Boer and R.W. Stam, Hypermethylation of specific microRNA genes in MLL-rearranged infant acute lymphoblastic leukemia: Major matters at a micro scale, Leukemia 25 (2011), 429-39.
77. L. Xu, Y.N. Liang, X.Q. Luo, X.D. Liu and H.X. Guo, [Association of miRNAs expression profiles with prognosis and relapse in childhood acute lymphoblastic leukemia], Zhonghua Xue Ye Xue Za Zhi 32 (2011), 178-81.
78. D.G. Schaar, D.J. Medina, D.F. Moore, R.K. Strair and Y. Ting, miR-320 targets transferrin receptor 1 (CD71) and inhibits cell proliferation, Exp Hematol 37 (2009), 245-55.
79. S.P. Nana-Sinkam and C.M. Croce, MicroRNA in chronic lymphocytic leukemia: Transitioning from laboratory-based investigation to clinical application, Cancer Genet Cytogenet 203 (2010), 127-33.
80. Y. Xi, J. Li, L. Zan, J. Wang, G. Wang and Y. Ning, Micro-RNA-16 expression in paraffin-embedded specimen correlates with overall survival of T-lymphoblastic lymphoma/leukemia, Hum Pathol (2012).
81. F. Wang, X.S. Wang, G.H. Yang, P.F. Zhai, Z. Xiao, L.Y. Xia, L.R. Chen, Y. Wang, X.Z. Wang, L.X. Bi, N. Liu, Y. Yu, D. Gao, B.T. Huang, J. Wang, D.B. Zhou, J.N. Gong, H.L. Zhao, X.H. Bi, J. Yu and J.W. Zhang, miR-29a and miR-142-3p downregulation and diagnostic implication in human acute myeloid leukemia, Mol Biol Rep 39 (2012), 2713-22.
82. D.L. Zanette, F. Rivadavia, G.A. Molfetta, F.G. Barbuzano, R. Proto-Siqueira, W.A. Silva-Jr, R.P. Falcao and M.A. Zago, miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia, Braz J Med Biol Res 40 (2007), 1435-40.
83. A.C. Russ, S. Sander, S.C. Luck, K.M. Lang, M. Bauer, F.G. Rucker, H.A. Kestler, R.F. Schlenk, H. Dohner, K. Holzmann, K. Dohner and L. Bullinger, Integrative nucleophosmin mutation-associated microRNA and gene expression pattern analysis identifies novel microRNA - target gene interactions in acute myeloid leukemia, Haematologica 96 (2011), 1783-91.
84. M. Diaz-Beya, A. Navarro, G. Ferrer, T. Diaz, B. Gel, M. Camos, M. Pratcorona, M. Torrebadell, M. Rozman, D. Colomer, M. Monzo and J. Esteve, Acute myeloid leukemia with translocation (8;16)(p11;p13) and MYST3-CREBBP rearrangement harbors a distinctive microRNA signature targeting RET proto-oncogene, Leukemia (2012).
85. S. Landais, S. Landry, P. Legault and E. Rassart, Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia, Cancer Res 67 (2007), 5699-707.
86. G. Ferrer, A. Navarro, K. Hodgson, M. Aymerich, A. Pereira, T. Baumann, M. Monzo, C. Moreno and E. Montserrat, MicroRNAs expression in chronic lymphocytic leukemia developing autoimmune hemolytic anemia, Leuk Lymphoma (2013).